Fig. 7.
Fig. 7. Tyrosine phosphorylation in neutrophils from healthy individuals and patients with severe sepsis. (A) Increased tyrosine phosphorylation in neutrophils from patients with sepsis. Freshly isolated neutrophils (1 × 106/mL) from healthy humans (control) and patients with severe sepsis (patient) were cultured with or without the protein-tyrosine phosphatase inhibitor phenylarsine oxide (PAO; 10 μmol/L) for 30 minutes at 37°C. (B) Inhibition of tyrosine phosphorylation in normal neutrophils by IL-10. Freshly isolated neutrophils (1 × 106/mL) from healthy humans were cultured with or without LPS (1 μg/mL) and rhIL-10 (100 U/mL) for 2 hours at 37°C. Levels of tyrosine phosphorylation were analyzed by flow cytometry after permeabilization with saponin and staining with antiphosphotyrosine (P-Tyr) and goat-antimouse FITC-conjugated antibodies. Both figures are representative of three other experiments that yielded the same results.

Tyrosine phosphorylation in neutrophils from healthy individuals and patients with severe sepsis. (A) Increased tyrosine phosphorylation in neutrophils from patients with sepsis. Freshly isolated neutrophils (1 × 106/mL) from healthy humans (control) and patients with severe sepsis (patient) were cultured with or without the protein-tyrosine phosphatase inhibitor phenylarsine oxide (PAO; 10 μmol/L) for 30 minutes at 37°C. (B) Inhibition of tyrosine phosphorylation in normal neutrophils by IL-10. Freshly isolated neutrophils (1 × 106/mL) from healthy humans were cultured with or without LPS (1 μg/mL) and rhIL-10 (100 U/mL) for 2 hours at 37°C. Levels of tyrosine phosphorylation were analyzed by flow cytometry after permeabilization with saponin and staining with antiphosphotyrosine (P-Tyr) and goat-antimouse FITC-conjugated antibodies. Both figures are representative of three other experiments that yielded the same results.

Close Modal

or Create an Account

Close Modal
Close Modal